ResMed Aktie
218,60
EUR
-3,60
EUR
-1,62
%
233,77
USD
+2,19
USD
+0,95
%
ResMed Aktie Analyse
| 14.12.18 | ResMed Outperform | BMO Capital Markets | |
| 23.01.18 | ResMed Hold | Needham & Company, LLC | |
| 25.09.17 | ResMed Underweight | Barclays Capital | |
| 04.08.17 | ResMed Outperform | BMO Capital Markets | |
| 24.01.17 | ResMed Hold | Canaccord Adams | |
| 27.06.16 | ResMed Underperform | Needham & Company, LLC | |
| 07.04.16 | ResMed Underweight | Barclays Capital | |
| 17.12.15 | ResMed Hold | Needham & Company, LLC | |
|
Werbung
|
|||
| 25.06.15 | ResMed Equal weight | Barclays Capital | |
| 14.05.15 | ResMed Buy | Needham & Company, LLC | |
| 27.01.15 | ResMed Under Perform | Northland Capital | |
| 23.01.15 | ResMed Hold | Canaccord Adams | |
| 23.01.15 | ResMed Buy | Needham & Company, LLC | |
| 07.08.12 | ResMed hold | Jefferies & Company Inc. | |
| 10.08.09 | ResMed overweight | JP Morgan Chase & Co. | |
| 30.03.09 | ResMed langfristig kaufen | BÖRSE am Sonntag | |
| 17.03.09 | ResMed market perform | Wachovia Securities, LLC | |
| 03.01.08 | ResMed market perform | Wachovia Sec | |
| 02.01.08 | ResMed above average | Caris & Company, Inc. | |
| 25.04.07 | ResMed buy | Caris & Company | |
| 14.03.07 | ResMed above average | Caris & Company | |
| 07.02.07 | ResMed Neutral | First Albany | |
| 21.09.06 | ResMed Hold | Kaufman Bros., LP | |
| 06.04.06 | ResMed | Focus Money | |
| 28.10.05 | ResMed kaufen | Erste Bank | |
| 04.02.05 | ResMed Buy | First Albany | |
| 04.02.05 | ResMed Outperform | Wachovia Sec | |